Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)

NCT02474160 is registered in ClinicalTrials.gov with National Cancer Institute LAO as lead sponsor.

NCT NCT02474160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02474160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Lead sponsor
National Cancer Institute LAO
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2015
Completion date
May 4, 2028
Enrollment
5,000 (estimated)
Sites
139

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphatic system neoplasm, malignant solid neoplasm, metastatic malignant solid neoplasm, recurrent malignant solid neoplasm